• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

vector technology

Handshake
Biotech

Homology scratches cash itch with $130M deal to fund trials

With its share price in the doldrums and its cash runway nearing its final year, Homology is offloading manufacturing assets through a joint venture.
Nick Paul Taylor Jan 28, 2022 8:00am
Gene therapy

Broad team proposes safer, more efficient AAVs for gene therapy

Sep 9, 2021 11:00am
Electromicrograph showing an HIV-infected T cell in blue and yellow

J&J's HIV vaccine fails phase 2b, extending long wait for a jab

Aug 31, 2021 8:30am
Roche

Roche's gene therapy plans take Shape with $3B-plus deal

Aug 24, 2021 11:05am
Ring Therapeutics CEO Tuyen Ong

Flagship-backed gene therapy Ring Therapeutics reels in $117M

Jul 28, 2021 8:00am
Amsterdam

VectorY raises $38M to develop Alzheimer's, ALS gene therapies

Jun 15, 2021 7:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings